-
As mentioned in prior posts, is Plavix a good candidate for personalized medicine, since it is a blood thinner. Right now with the new warning, it is basically telling you that it might not work for you so with a test perhaps the guess work someday could be eliminated. FDA To look at benefits...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Fri, Mar 12 2010
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Physician, personalized medicine, DNA, Genomics, healthcare, Health IT, Cardiology, Biotech, FDA, Information Overload, Pharmacogenomics, Sequencing, FDA warnings, Plavix
-
We are back to the same 3 companies again, Johnson and Johnson, Boston Scientific and Abbott, same questions over “patents” and more legal expenses to pass along to consumers in the price of a stent. If these 3 could settle their differences and make some donations for charity instead of all these...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sat, Mar 6 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Medical Devices, Pharma, Biotech, FDA, Stents, Recalls, Legal Suits, Investments, Boston Scientific, Microsoft Tags, Johnson and Johson
-
I am not picking per se here, but gee every time I turn around I keep hearing about one suit after another with appeals, awards, etc. all going back to “patent wars”, and with present economic conditions, who cares. All I know is that consumers end up paying in the long run for all of this and...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sun, Feb 21 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Medical Devices, Pharma, Biotech, FDA, Recalls, Legal Suits, Investments, Boston Scientific, CE Mark, Microsoft Tags, Johnson and Johson
-
Basilea Pharmaceutica and Johnson and Johnson worked together on the drug for MRSA infections and after not meeting quality and monitoring standards with both the FDA and European Regulators, J and J says goodbye to Basilea and you are on your own, no more money. J and J conducted the trials...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sun, Feb 21 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Medical Devices, Pharma, Biotech, FDA, MRSA, Recalls, Legal Suits, Investments, CE Mark, Microsoft Tags, Johnson and Johson, Basilea Pharmaceutica
-
The rats are doing well and the article states that the walking ability was restored to 97 percent. This could hold some real big answers to those who have spinal cord damages and being able to function without paralysis of the limbs. Geron was one of the first companies given the go ahead...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Nov 10 2009
Filed under:
Filed under: Medically Related, Technology, healthcare, Biotech, FDA, clinical trials, R and D, Stem Cells, Geron, UCI Irvine, embryonic stem cells
-
The drug, Aranesp is used with chemotherapy and chronic renal failure to increase red blood cells and was approved by the FDA in 2001. We are hearing more about drug marketing today and now it’s spilling over to the “biotech” drug companies for investigation. The suit states that providers were bribed...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sat, Oct 31 2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, medicare, Lawsuit, Biotech, Marketing, Amgen, drug samples, billing, anemia, bribes, Aranesp, overfill
-
RNA-based aptamer technology is a new approach to make safer drugs, and allows for the creation of the drug along with the antidote at the same time. In this article, blood thinning agents are used as an example. Blood thinning agents are one of the most difficult classes of drugs to coordinate...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sun, Oct 4 2009
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, drugs, healthcare, Proteins, Pharma, Biotech, clinical trials, warfarin, Pharmacogenomics, Research and Development, molecular drug data, The Watchman, Aptamer, nucleic acid
-
The battle for intellectual property is building up with the companies in the sequencing business. A few months ago Illumina filed a legal suit. How this will all work out will be interesting to see. I just posted today about another newcomer that intends to drive pricing even down...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Fri, Sep 25 2009
Filed under:
Filed under: Medically Related, Technology, personalized medicine, Genomics, healthcare, Biotech, Science, R and D, Intellectual property, Sequencing Machines, Illumina, arrays, Life Technologies
-
Not too long ago I posed about a Scientist at Pfizer and her story on what happened and how she became ill. There’s quite a bit to it including an explosion at the facility where she worked and disposal of lab material. This story today talks about a death so perhaps standards on working...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Sep 21 2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, Physician, Genomics, healthcare, Lawsuit, Biotech, Pfizer, R and D, Safety, virus, stem cell research, embryonic stem cells, OSHA, chemist chemical spill, exposure, viruses, persoanlized medicine
-
Last year I was luck enough to spend a bit time talking with Dr. Patrice Milos, Chief Science Officer for Helicos who explained the entire process to me, an interesting read and in layman’s terms pretty much. One thing that the doctor and I both whole heartedly agreed on is that “it is all about...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Aug 11 2009
Filed under:
Filed under: Medically Related, Technology, Insurance, Other Items of Interest, personalized medicine, Genomics, healthcare, Electronic Medical Records, Biotech, cancer research, Research, Gene Sequencing, Stanford, Disease, Stanford University, DNA Testing, Phamaceuticals, Helicos, Donation
-
As drug patents begin to expire, pharma is looking for ways to fill the pipelines and biotech drugs appear to be one of the hottest avenues to fill the pipelines, we recently saw Cougar Biotech purchased by J and J. One thing I think we forget about though is that we don’t have the lock on cancer...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sat, Jul 11 2009
Filed under:
Filed under: Medically Related, Technology, My Commentaries, healthcare, Pharma, Biotech, R and D, Patents, Stocks, Intellectual property, Bristol-Myer Squibb, ImClone, trading
-
This is very interesting listening to one molecular researcher speaking about safety in the work place, unlike other workplace areas, Biotech areas are not covered by OSHA. The molecular researcher caught a virus from someone else doing work at here workstation. The video is well worth listening...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sat, Jul 11 2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, Physician, Genomics, healthcare, Lawsuit, Biotech, Pfizer, R and D, Safety, virus, stem cell research, embryonic stem cells, OSHA, chemist chemical spill, exposure, viruses, persoanlized medicine
-
The technology is not slated to be ready for prime time for at least another 5 years, so I guess Viagra and Cialis are still safe. The entire process is to help men who are infertile. Here’s a couple other related Sperm posts of interest. BD Sperm Made from Female Stem Cells-...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Jul 7 2009
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Genetics, healthcare, Biotech, Science, Fertility, Stem Cells, sperm, eggs
-
It is finally beginning to take place, looking to see where there are possible duplicated efforts as well as trying to determine whether perhaps a device or a drug is the best answer for certain treatments and of course, cost is right in there. One good example in the text below is the treatment...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sun, Jul 5 2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Medical Devices, Pharma, Biotech, Cancer, Hospitals, Treatment, Obama Healthcare, heart illness
-
This is a little different as we all read about computer viruses so much, but this is a real contamination issue. The plant had issues back in 2008 with a warning letter from the FDA. The plant makes drugs that treat enzyme deficiencies, so it is a small amount of the population that is affected...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Jun 17 2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, Biotech, FDA, contamination, virus, Genzyme, Enzyme deficiencies, orphan drugs